<DOC>
	<DOC>NCT00150696</DOC>
	<brief_summary>The purpose of this study is to find out if Risedronate works to prevent osteoporosis after spinal cord injury.</brief_summary>
	<brief_title>Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Traumatic spinal cord injury less than 100 days. Must be able to swallow tablets and sit upright. Bilateral knee flexion contractures. Pregnant, lactating or postmenopausal females. Paget's disease, osteomalacia, steroid induced bone loss, untreated thyroid disease, iritis, uveitis, pancreatitis, gastritis, peptic ulcer or cholecystitis. Treatment in the last year with calcitonin, fluoride or anabolic steroid. Concurrent treatment with prednisone.</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Osteoporosis</keyword>
	<keyword>Spinal Cord Injury</keyword>
</DOC>